UQ researchers are buoyed by investment in promising heart attack treatment. (Left to right, Associate Professor Nathan Palpant, Associate Professor Mark Smythe and Professor Glenn King). Supplied.

A potentially life-saving treatment containing venom from one of the world’s deadliest spiders is one step closer to human trials, thanks to a $23 million investment in a Brisbane startup.

4 July 2022
A woman stands in front of a blue background with graphic depiction of DNA

University of Queensland researchers have demonstrated a genetic link between endometriosis and ovarian cancer subtypes enabling them to identify potential drug targets for therapy and increasing the understanding of both diseases.

16 March 2022